Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.06% | -22.99% | -63.49% | -36.49% | -31.58% |
| Total Depreciation and Amortization | -6.62% | -11.70% | 13.91% | -1.72% | -16.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -693.78% | -947.05% | -87.98% | 222.98% | 84.70% |
| Change in Net Operating Assets | 1,092.19% | -73.41% | 517.87% | -177.45% | -37.30% |
| Cash from Operations | 75.85% | -470.62% | 69.27% | -131.70% | 50.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.91% | -569.18% | 3,440.27% | -- | 100.00% |
| Cash from Investing | 135.91% | -569.18% | 3,440.27% | -- | 100.00% |
| Total Debt Issued | 434.15% | -2,004.40% | -94.46% | -- | -- |
| Total Debt Repaid | -547.83% | 68.49% | 0.68% | 41.90% | 53.83% |
| Issuance of Common Stock | -78.92% | 282.19% | 521.93% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.38% | 265.26% | 224.37% | 2,356.75% | 54.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,642.70% | -109.43% | 238.52% | -62.71% | 56.95% |